GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CNBX Pharmaceuticals Inc (OTCPK:CNBX) » Definitions » Cyclically Adjusted Book per Share

CNBX (CNBX Pharmaceuticals) Cyclically Adjusted Book per Share : $2.90 (As of Feb. 2025)


View and export this data going back to 2007. Start your Free Trial

What is CNBX Pharmaceuticals Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

CNBX Pharmaceuticals's adjusted book value per share for the three months ended in Feb. 2025 was $-0.076. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.90 for the trailing ten years ended in Feb. 2025.

During the past 12 months, CNBX Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was -8.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 30.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 13.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of CNBX Pharmaceuticals was 30.30% per year. The lowest was -37.20% per year. And the median was -18.60% per year.

As of today (2025-05-18), CNBX Pharmaceuticals's current stock price is $0.0012. CNBX Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Feb. 2025 was $2.90. CNBX Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 0.00.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of CNBX Pharmaceuticals was 60.84. The lowest was 0.01. And the median was 15.69.


CNBX Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

The historical data trend for CNBX Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CNBX Pharmaceuticals Cyclically Adjusted Book per Share Chart

CNBX Pharmaceuticals Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.43 1.45 2.19 3.14 3.21

CNBX Pharmaceuticals Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.17 3.21 3.21 3.04 2.90

Competitive Comparison of CNBX Pharmaceuticals's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, CNBX Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CNBX Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CNBX Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where CNBX Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


;
;

CNBX Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CNBX Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Feb. 2025 was:

Adj_Book= Book Value per Share /CPI of Feb. 2025 (Change)*Current CPI (Feb. 2025)
=-0.076/134.6241*134.6241
=-0.076

Current CPI (Feb. 2025) = 134.6241.

CNBX Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201505 5.050 100.333 6.776
201508 -0.366 100.548 -0.490
201511 0.184 100.135 0.247
201602 -0.465 100.040 -0.626
201605 -0.447 101.355 -0.594
201608 -0.523 101.617 -0.693
201611 -0.242 101.829 -0.320
201702 -0.186 102.779 -0.244
201705 2.918 103.256 3.804
201708 2.951 103.587 3.835
201711 2.432 104.072 3.146
201802 3.235 105.052 4.146
201805 2.618 106.148 3.320
201808 2.612 106.383 3.305
201811 8.254 106.338 10.450
201902 16.305 106.649 20.582
201905 17.248 108.048 21.490
201908 13.153 108.245 16.358
201911 5.376 108.519 6.669
202002 2.801 109.139 3.455
202005 4.528 108.175 5.635
202008 1.567 109.662 1.924
202011 1.114 109.793 1.366
202102 3.357 110.968 4.073
202105 1.963 113.576 2.327
202108 1.458 115.421 1.701
202111 0.506 117.269 0.581
202202 -0.520 119.703 -0.585
202205 -0.954 123.323 -1.041
202208 -1.297 124.958 -1.397
202211 -1.569 125.607 -1.682
202302 -0.911 126.928 -0.966
202305 -0.119 128.314 -0.125
202308 -0.089 129.538 -0.092
202311 -0.074 129.548 -0.077
202402 -0.076 130.930 -0.078
202405 -0.079 132.509 -0.080
202408 -0.080 132.816 -0.081
202411 -0.081 133.110 -0.082
202502 -0.076 134.624 -0.076

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


CNBX Pharmaceuticals  (OTCPK:CNBX) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

CNBX Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.0012/2.90
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of CNBX Pharmaceuticals was 60.84. The lowest was 0.01. And the median was 15.69.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


CNBX Pharmaceuticals Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of CNBX Pharmaceuticals's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


CNBX Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
No. 3 Bethesda Metro Center, Suite 700, Bethesda, MD, USA, 20814
CNBX Pharmaceuticals Inc is a clinical-stage biotechnology company. It develops pharmaceuticals focusing on cancer research utilizing HTS technology and personalized bioinformatics tools. The company's main focus is the development of cannabinoid therapies and other technologies for the treatment of cancer, mainly cancers of the gastrointestinal tract, skin, breast, and prostate. The firm's main product is the Cannabics SR, an oral capsule developed for the treatment of patients with cancer and cancer anorexia cachexia syndrome (CACS). It also has an anti-neoplastic drug candidate under development for Colorectal Cancer (CRC) named RCC-33.
Executives
Cannabics Inc. 10 percent owner 108 WEST 13TH ST., WILMINGTON DE 19801
Thomas E Mills director, officer: President, CEO, CFO
North American Mining Corp 10 percent owner 6767 WEST TROPICANA AVENUE, SUITE 229, LAS VEGAS NV 89103
Lou Hilford director, officer: Vice-President, Secretary